Global Anticancer Drugs Market Segment Research Report 2024
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Anticancer Drugs Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Anticancer Drugs industry at home and abroad, estimate the overall market scale of the Anticancer Drugs industry and the market share of major countries, Anticancer Drugs industry, and study and judge the downstream market demand of Anticancer Drugs through systematic research, Analyze the competition pattern of Anticancer Drugs, so as to help solve the pain points of various stakeholders in Anticancer Drugs industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Anticancer Drugs Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Anticancer Drugs Market?
F. Hoffmann-La Roche Ltd
Novartis AG
Bayer AG
Eli Lilly and Company
Amgen Inc
AstraZeneca
Pfizer Inc
Merck & Co., Inc.
Takeda Pharmaceutical Company Limited
...
Major Type of Anticancer Drugs Covered in XYZResearch report
Hormonal Drugs
Targeted Drugs
Cytotoxic Drugs
Application Segments Covered in XYZResearch Market
Chemotherapy
Immunotherapy
Targeted Therapy
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Anticancer Drugs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Anticancer Drugs Market by Value
2.2.1 Global Anticancer Drugs Revenue by Type
2.2.2 Global Anticancer Drugs Market by Value (%)
2.3 Global Anticancer Drugs Market by Production
2.3.1 Global Anticancer Drugs Production by Type
2.3.2 Global Anticancer Drugs Market by Production (%)
3. The Major Driver of Anticancer Drugs Industry
3.1 Historical & Forecast Global Anticancer Drugs Demand
3.2 Largest Application for Anticancer Drugs (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Anticancer Drugs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Anticancer Drugs Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Anticancer Drugs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Anticancer Drugs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Anticancer Drugs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Anticancer Drugs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Anticancer Drugs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Anticancer Drugs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Anticancer Drugs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Anticancer Drugs Average Price Trend
12.1 Market Price for Each Type of Anticancer Drugs in US (2018-2022)
12.2 Market Price for Each Type of Anticancer Drugs in Europe (2018-2022)
12.3 Market Price for Each Type of Anticancer Drugs in China (2018-2022)
12.4 Market Price for Each Type of Anticancer Drugs in Japan (2018-2022)
12.5 Market Price for Each Type of Anticancer Drugs in India (2018-2022)
12.6 Market Price for Each Type of Anticancer Drugs in Korea (2018-2022)
12.7 Market Price for Each Type of Anticancer Drugs in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Anticancer Drugs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Anticancer Drugs
14. Anticancer Drugs Competitive Landscape
14.1 F. Hoffmann-La Roche Ltd
14.1.1 F. Hoffmann-La Roche Ltd Company Profiles
14.1.2 F. Hoffmann-La Roche Ltd Product Introduction
14.1.3 F. Hoffmann-La Roche Ltd Anticancer Drugs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Novartis AG
14.2.1 Novartis AG Company Profiles
14.2.2 Novartis AG Product Introduction
14.2.3 Novartis AG Anticancer Drugs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Bayer AG
14.3.1 Bayer AG Company Profiles
14.3.2 Bayer AG Product Introduction
14.3.3 Bayer AG Anticancer Drugs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Eli Lilly and Company
14.4.1 Eli Lilly and Company Company Profiles
14.4.2 Eli Lilly and Company Product Introduction
14.4.3 Eli Lilly and Company Anticancer Drugs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Amgen Inc
14.5.1 Amgen Inc Company Profiles
14.5.2 Amgen Inc Product Introduction
14.5.3 Amgen Inc Anticancer Drugs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 AstraZeneca
14.6.1 AstraZeneca Company Profiles
14.6.2 AstraZeneca Product Introduction
14.6.3 AstraZeneca Anticancer Drugs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Pfizer Inc
14.7.1 Pfizer Inc Company Profiles
14.7.2 Pfizer Inc Product Introduction
14.7.3 Pfizer Inc Anticancer Drugs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Merck & Co., Inc.
14.8.1 Merck & Co., Inc. Company Profiles
14.8.2 Merck & Co., Inc. Product Introduction
14.8.3 Merck & Co., Inc. Anticancer Drugs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Takeda Pharmaceutical Company Limited
14.9.1 Takeda Pharmaceutical Company Limited Company Profiles
14.9.2 Takeda Pharmaceutical Company Limited Product Introduction
14.9.3 Takeda Pharmaceutical Company Limited Anticancer Drugs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 ...
14.10.1 ... Company Profiles
14.10.2 ... Product Introduction
14.10.3 ... Anticancer Drugs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
15. Conclusion
16. Methodology and Data Source
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Anticancer Drugs Industry (Volume)
Figure 2. Anticancer Drugs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Anticancer Drugs Revenue in 2022
Figure 5. US Anticancer Drugs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Anticancer Drugs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Anticancer Drugs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Anticancer Drugs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Anticancer Drugs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Anticancer Drugs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Anticancer Drugs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Anticancer Drugs Revenue, by Type (Million USD) (2018-2028)
Table 4. Anticancer Drugs Production, by Type (K Unit) (2018-2028)
Table 5. Anticancer Drugs Demand (K Unit) by Application (2018-2028)
Table 6. Anticancer Drugs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Anticancer Drugs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Anticancer Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Anticancer Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Anticancer Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Anticancer Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Anticancer Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Anticancer Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Anticancer Drugs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Anticancer Drugs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Anticancer Drugs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Anticancer Drugs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Anticancer Drugs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Anticancer Drugs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Anticancer Drugs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Anticancer Drugs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. F. Hoffmann-La Roche Ltd Profiles
Table 61. F. Hoffmann-La Roche Ltd Anticancer Drugs Product Introduction
Table 62. F. Hoffmann-La Roche Ltd Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. F. Hoffmann-La Roche Ltd Strategic initiatives
Table 64. Novartis AG Profiles
Table 65. Novartis AG Anticancer Drugs Product Introduction
Table 66. Novartis AG Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Novartis AG Strategic initiatives
Table 68. Bayer AG Profiles
Table 69. Bayer AG Anticancer Drugs Product Introduction
Table 70. Bayer AG Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Bayer AG Strategic initiatives
Table 72. Eli Lilly and Company Profiles
Table 73. Eli Lilly and Company Anticancer Drugs Product Introduction
Table 74. Eli Lilly and Company Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Eli Lilly and Company Strategic initiatives
Table 76. Amgen Inc Profiles
Table 77. Amgen Inc Anticancer Drugs Product Introduction
Table 78. Amgen Inc Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Amgen Inc Strategic initiatives
Table 80. AstraZeneca Profiles
Table 81. AstraZeneca Anticancer Drugs Product Introduction
Table 82. AstraZeneca Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. AstraZeneca Strategic initiatives
Table 84. Pfizer Inc Profiles
Table 85. Pfizer Inc Anticancer Drugs Product Introduction
Table 86. Pfizer Inc Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Pfizer Inc Strategic initiatives
Table 88. Merck & Co., Inc. Profiles
Table 89. Merck & Co., Inc. Anticancer Drugs Product Introduction
Table 90. Merck & Co., Inc. Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Merck & Co., Inc. Strategic initiatives
Table 92. Takeda Pharmaceutical Company Limited Profiles
Table 93. Takeda Pharmaceutical Company Limited Anticancer Drugs Product Introduction
Table 94. Takeda Pharmaceutical Company Limited Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Takeda Pharmaceutical Company Limited Strategic initiatives
Table 97. ... Profiles
Table 98. ... Anticancer Drugs Product Introduction
Table 99. ... Anticancer Drugs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. ... Strategic initiatives
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices